FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Guerbet Optiray 320 Recall

Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1…

GUERBET LLC · Princeton, NJ

Risk level
Class II
Reported by FDA
Oct 16, 2019
Recall ID
D-0137-2020
Check your lot numberHow we source this data

Summary

Guerbet recalled Optiray 320 starting Sep 13, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0137-2020 on Oct 16, 2019. Reason: Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.

Product description

Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1323-00.

Lot numbers, UPCs & expiration codes

Lots: L141C, L162A Exp. 06/2021; L146DS, Exp. 05/2021

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0137-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 13, 2019
FDA report date
Oct 16, 2019
Quantity
3860 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
GUERBET LLC

Original FDA data

Every field from FDA enforcement report D-0137-2020, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
83798
Address
821 Alexander Rd, Ste 204
Address (line 2)
120 W 7th St Suite
Code information
Lots: L141C, L162A Exp. 06/2021; L146DS, Exp. 05/2021
Postal code
08540-0000
Report date
Oct 16, 2019
Product type
Drugs
Recall number
D-0137-2020
Classification
Class II
Recalling firm
GUERBET LLC
Product quantity
3860 syringes
Termination date
Oct 25, 2021
Reason for recall
Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1323-00.
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 13, 2019
Initial firm notification
Letter
Center classification date
Oct 9, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0137-2020, published Oct 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls